Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors

Cancer

Volumn 117, Issue 2, 2011, Pages 380-389

  Ylipää, Antti ^a,b   Hunt, Kelly K ^c   Yang, Jilong ^a,d   Lazar, Alexander J F ^a,c   Torres, Keila E ^c   Lev, Dina C ^c   Nykter, Matti ^b   Pollock, Raphael E ^c   Trent, Jonathan ^c   Zhang, Wei ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF TEXAS   (United States)

^d TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

array comparative genomic hybridization; copy number aberrations; gastrointestinal stromal tumors; imatinib; leiomyosarcoma; survival; v kit Hardy Zuckerman 4 feline sarcoma viral oncogene homolog

Indexed keywords

IMATINIB; STEM CELL FACTOR RECEPTOR;

ADULT; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 10; CHROMOSOME 14Q; CHROMOSOME 15Q; CHROMOSOME 16; CHROMOSOME 1P; CHROMOSOME 22Q; CHROMOSOME LOSS; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION PROFILING; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALE; MITOSIS INDEX; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; FEMALE; GASTROINTESTINAL STROMAL TUMORS; GENE EXPRESSION PROFILING; GENOMIC INSTABILITY; HUMANS; LEIOMYOSARCOMA; MALE; MIDDLE AGED; PROGNOSIS; SIGNAL TRANSDUCTION;

EID: 78650972191     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25594     Document Type: Article

References (26)

1. Price ND, Trent J, El-Naggar AK, et al. Highly accurate 2-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad Sci U S A. 2007; 104: 3414-3419.
2. Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003; 299: 708-710.
3. Demetri GD, Benjamin RS, Blanke CD, et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)a update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw. 2007; 5 (suppl 2): S1-S29.
4. Joensuu H,. Gastrointestinal stromal tumor (GIST). Ann Oncol. 2006; 17 (suppl 10): x280-x286.
5. Hensley ML, Maki R, Venkatraman E, et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol. 2002; 20: 2824-2831.
6. Chen LL, Trent JC, Wu EF, et al. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res. 2004; 64: 5913-5919.
7. Fearon ER, Vogelstein B,. A genetic model for colorectal tumorigenesis. Cell. 1990; 61: 759-767.
8. Olshen AB, Venkatraman ES, Lucito R, Wigler M,. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics. 2004; 5: 557-572.
9. van de Wiel MA, Kim KI, Vosse SJ, van Wieringen WN, Wilting SM, Ylstra B,. CGHcall: calling aberrations for array CGH tumor profiles. Bioinformatics. 2007; 23: 892-894.
10. Meza-Zepeda LA, Kresse SH, Barragan-Polania AH, et al. Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. Cancer Res. 2006; 66: 8984-8993.
11. Wang R, Lu YJ, Fisher C, Bridge JA, Shipley J,. Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-4-color karyotyping and comparative genomic hybridization analysis. Genes Chromosomes Cancer. 2001; 31: 54-64.
12. El-Rifai W, Sarlomo-Rikala M, Knuutila S, Miettinen M,. DNA copy number changes in development and progression in leiomyosarcomas of soft tissues. Am J Pathol. 1998; 153: 985-990. (Pubitemid 28419051)
13. Otano-Joos M, Mechtersheimer G, Ohl S, et al. Detection of chromosomal imbalances in leiomyosarcoma by comparative genomic hybridization and interphase cytogenetics. Cytogenet Cell Genet. 2000; 90: 86-92.
14. Riva P, Dalpra L, Gualandri V, et al. 19p Deletion in recurring leiomyosarcoma lesions from the same patient. Cancer Genet Cytogenet. 2000; 119: 102-108.
15. Derre J, Lagace R, Nicolas A, et al. Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas. Lab Invest. 2001; 81: 211-215.
16. Mandahl N, Fletcher CD, Dal Cin P, et al. Comparative cytogenetic study of spindle cell and pleomorphic leiomyosarcomas of soft tissues: a report from the CHAMP Study Group. Cancer Genet Cytogenet. 2000; 116: 66-73.
17. Yang J, Du X, Chen K, et al. Genetic aberrations in soft tissue leiomyosarcoma. Cancer Lett. 2009; 275: 1-8.
18. Wang R, Titley JC, Lu YJ, et al. Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma. Mod Pathol. 2003; 16: 778-785.
19. Hu J, Rao UN, Jasani S, Khanna V, Yaw K, Surti U,. Loss of DNA copy number of 10q is associated with aggressive behavior of leiomyosarcomas: a comparative genomic hybridization study. Cancer Genet Cytogenet. 2005; 161: 20-27.
20. Larramendy ML, Kaur S, Svarvar C, Bohling T, Knuutila S,. Gene copy number profiling of soft-tissue leiomyosarcomas by array-comparative genomic hybridization. Cancer Genet Cytogenet. 2006; 169: 94-101.
21. Yang J, Du X, Lazar AJ, et al. Genetic aberrations of gastrointestinal stromal tumor. Cancer. 2008; 113: 1532-1543.
22. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25: 25-29.
23. Verhaak RGW, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010; 17: 98-110.
24. Purow B, Shiff D,. Advances in the genetics of glioblastoma: are we reaching the critical mass? Nat Rev Neurol. 2009; 5: 419-426.
25. Cavenee WK, Scrable HJ, James CD,. Molecular genetics of human cancer predisposition and progression. Mutat Res. 1991; 247: 199-202.
26. El-Rifai W, Sarlomo-Rikala M, Andersson LC, Knuutila S, Miettinen M,. DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. Cancer Res. 2000; 60: 3899-3903.